Company Filing History:
1 out of 8 
1 out of 1 Years Active: 2022-2025
Title: Innovations of Jianhe Chen in Antibody Development
Introduction
Jianhe Chen is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. He holds two patents that focus on innovative antibody therapies aimed at treating diseases related to human HER2 overexpression and enhancing immune responses against tumors.
Latest Patents
One of Jianhe Chen's latest patents is titled "Antibody binding to human HER2 and preparation method and use thereof." This invention provides an antibody that specifically binds to human HER2, demonstrating improved biological activity in inhibiting the proliferation of tumor cells that overexpress HER2. Compared to existing treatments like Perjeta, the combination of this antibody and Herceptin shows promising results in clinical applications for cancer treatment.
Another notable patent is the "Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof." This invention involves an anti-human PD-1 monoclonal antibody that effectively binds to the extracellular region of the human PD-1 protein receptor. It plays a crucial role in blocking the interaction between PD-1 and its ligand PD-L1, thereby enhancing immune responses. This monoclonal antibody has potential applications in tumor immunotherapy and the treatment of autoimmune diseases.
Career Highlights
Jianhe Chen has worked with Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., where he has contributed to the development of innovative therapeutic solutions. His work in this company has been instrumental in advancing research in antibody therapies.
Collaborations
Throughout his career, Jianhe Chen has collaborated with notable professionals in the field, including Le Zhao and Haomin Huang. These collaborations have further enriched his research and development efforts.
Conclusion
Jianhe Chen's innovative work in antibody development showcases his commitment to advancing medical science and improving treatment options for patients. His patents reflect a promising future in the field of biotechnology and cancer therapy.